Research: SHAH and COLLEAGUES,

Listed in Issue 193

Abstract

SHAH and COLLEAGUES, Department of Pediatric Surgery, University of Texas Medical School at Houston, Houston, Texas 77030, USA review the published evidence regarding the use, efficacy, potential mechanisms of action, and results of published clinical trials regarding the use of a Lentinula edodes mushroom-derived extract (active hexose correlated compound) in cancer patient trials.

Background

The purpose of this review is to present the currently published evidence regarding the use, efficacy, potential mechanisms of action, and results of published clinical trials regarding the use of a Lentinula edodes mushroom-derived extract (active hexose correlated compound) as complementary therapy in patients with cancer.

Methodology

The authors explore the current preclinical and clinical evidence as it relates to this topic and its potential use in the surgical oncology patient.

Results

There has been a growing interest in stimulation of the immune system in trauma, cancer, and surgical patients in general. Little, however, has been written about some-of the supplements in widely used in Japan and China, but relatively unheard of in the United States.

Conclusion

References

Shah SK,  Walker PA,  Moore-Olufemi SD,  Sundaresan A,  Kulkarni AD and  Andrassy RJ. An evidence-based review of a Lentinula edodes mushroom extract as complementary therapy in the surgical oncology patient. [Review] Jpen: Journal of Parenteral & Enteral Nutrition. 35(4): 449-58. Jul 2011.

ICAN 2024 Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

top of the page